STOCK TITAN
  1. Home
  2. Sec-filings
  3. BNR
  4. [Form 4] Burning Rock Biotech Ltd Insider Trading Activity

Burning Rock (BNR) director adds 731,410 shares in seven open-market buys

Filing Impact
(Very High)
Filing Sentiment
(Very Positive)
Form Type
4

Rhea-AI Filing Summary

Burning Rock Biotech director Han Yusheng reported a series of open-market share purchases. Between June 11 and June 26, 2026, he bought a total of 731,410 ordinary shares (represented by American depositary shares) in seven separate transactions.

Individual trades ranged from 24,760 shares at $8.7394 per ADS to 250,000 shares at $8.0000 per ADS. After the most recent transaction, Han directly owned 18,404,086 ordinary shares. One American depositary share represents ten Class A ordinary shares, and all reported trades are non-derivative open-market purchases.

Positive

  • None.

Negative

  • None.
Insider Han Yusheng
Role null
Bought 731,410 shs ($6.18M)
Type Security Shares Price Value
Purchase Ordinary Shares (represented by American depositary shares) 24,900 $7.9956 $199K
Purchase Ordinary Shares (represented by American depositary shares) 250,000 $8.00 $2.00M
Purchase Ordinary Shares (represented by American depositary shares) 5,990 $7.4992 $45K
Purchase Ordinary Shares (represented by American depositary shares) 104,650 $7.4503 $780K
Purchase Ordinary Shares (represented by American depositary shares) 111,110 $8.9997 $1000K
Purchase Ordinary Shares (represented by American depositary shares) 210,000 $9.2483 $1.94M
Purchase Ordinary Shares (represented by American depositary shares) 24,760 $8.7394 $216K
Holdings After Transaction: Ordinary Shares (represented by American depositary shares) — 18,404,086 shares (Direct, null)
Footnotes (1)
  1. One American depositary share represents ten Class A ordinary shares. The reported price is the price of each ADS acquired.
Total shares purchased 731,410 shares Net open-market purchases across seven transactions
Largest single purchase 250,000 shares at $8.0000 per ADS Open-market transaction on June 24, 2026
Holdings after latest trade 18,404,086 shares Direct ownership following June 26, 2026 purchase
June 26 purchase 24,900 shares at $7.9956 per ADS Most recent reported open-market transaction
June 12 purchase 210,000 shares at $9.2483 per ADS One of seven non-derivative purchases
ADS to ordinary ratio 1 ADS = 10 Class A ordinary shares Stated in footnote for Burning Rock ADS
open-market purchase financial
"Transaction action is described as an open-market purchase for each trade."
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
American depositary share financial
"Ordinary shares are represented by American depositary shares in these trades."
An American Depositary Share (ADS) is a U.S.-listed certificate that represents a specified number of shares in a foreign company, held by a custodian bank; it works like a receipt that allows U.S. investors to buy and trade foreign equity on American exchanges without dealing with another country’s markets. Investors care because ADSs make foreign stocks easier to access, improve liquidity and settlement in dollars, and can affect dividend payments, voting rights and regulatory oversight compared with buying the underlying foreign shares directly.
non-derivative financial
"Each transaction is classified as a non-derivative security transaction."
Form 4 regulatory
"Insider activity is reported on a Form 4 for Burning Rock Biotech."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Class A ordinary shares financial
"One American depositary share represents ten Class A ordinary shares."
Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Han Yusheng
(Last)(First)(Middle)
NO. 46 - 2000 JIANHE ROAD
(Street)
SHANGHAI200336
(City)(State)(Zip)
CHINA
(Country)		2. Issuer Name and Ticker or Trading Symbol
Burning Rock Biotech Ltd [ BNR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares (represented by American depositary shares)(1)06/11/2026P24,760A$8.7394(2)17,697,436D
Ordinary Shares (represented by American depositary shares)(1)06/12/2026P210,000A$9.2483(2)17,907,436D
Ordinary Shares (represented by American depositary shares)(1)06/16/2026P111,110A$8.9997(2)18,018,546D
Ordinary Shares (represented by American depositary shares)(1)06/22/2026P104,650A$7.4503(2)18,123,196D
Ordinary Shares (represented by American depositary shares)(1)06/23/2026P5,990A$7.4992(2)18,129,186D
Ordinary Shares (represented by American depositary shares)(1)06/24/2026P250,000A$8(2)18,379,186D
Ordinary Shares (represented by American depositary shares)(1)06/26/2026P24,900A$7.9956(2)18,404,086D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. One American depositary share represents ten Class A ordinary shares.
2. The reported price is the price of each ADS acquired.
/s/ Yuheng Huang, Attorney-in-Fact for Yusheng Han07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Burning Rock Biotech (BNR) report on this Form 4?

Burning Rock Biotech director Han Yusheng reported a series of open-market purchases of ordinary shares represented by ADS between June 11 and June 26, 2026, totaling 731,410 shares across seven non-derivative transactions.

How many Burning Rock Biotech (BNR) shares did Han Yusheng buy?

Across seven open-market trades, Han Yusheng acquired 731,410 ordinary shares of Burning Rock Biotech. Each transaction involved ordinary shares represented by ADS, with trade sizes ranging from 5,990 shares to 250,000 shares in a single purchase.

At what prices did Han Yusheng buy Burning Rock Biotech (BNR) shares?

The reported prices are per ADS, which represents ten Class A ordinary shares. Transactions include $7.4503, $7.4992, $7.9956, $8.0000, $8.7394, $8.9997 and $9.2483 per ADS for the various purchase dates.

What is Han Yusheng’s ownership in Burning Rock Biotech (BNR) after these trades?

Following the most recent reported purchase, Han Yusheng directly holds 18,404,086 ordinary shares of Burning Rock Biotech. These holdings reflect only non-derivative ordinary shares represented by ADS and do not include any derivative securities in this filing.

How many transactions are disclosed in this Burning Rock Biotech (BNR) Form 4?

The Form 4 details seven separate non-derivative transactions. All are coded as P, indicating purchases, and are classified as open-market purchases of ordinary shares represented by American depositary shares, with no reported sales, gifts, or option exercises.

What is the ADS to ordinary share ratio for Burning Rock Biotech (BNR)?

According to the footnotes, one American depositary share represents ten Class A ordinary shares of Burning Rock Biotech. The reported transaction prices refer to the price of each ADS acquired, not directly to a single ordinary share.